Clinical Trials in Tennessee

Showing 7381-7400 of 20,239 trials

Phase I/II Study of KRN330 Plus Irinotecan in Patients With Metastatic Colorectal Cancer

NCT00838578

The primary objective of the Phase II portion of this study is to assess the efficacy of KRN330 in combination with irinotecan after first-line or adjuvant FOLFOX (5-fluorouracil, leucovorin, and oxaliplatin)/CapOx (capecitabine and oxaliplatin) treatment failure in patients with metastatic colorectal cancer.

Colorectal Cancer

Kyowa Kirin Co., Ltd.65 participantsStarted Mar 2009

Huntsville, Alabama, United States • Tucson, Arizona, United States • Los Angeles, California, United States +9 more locations

COMPLETEDPhase 329 miles

A Study Evaluating JUVÉDERM® VOLUMA® XC Injectable Gel for Correction of Temple Hollowing in Adult Participants ≥ 22 Years Old

NCT04414397

The objectives of this study are to evaluate the safety and effectiveness of Juvederm® Voluma® XC injectable gel in adult participants seeking correction of temple hollowing

Temple Hollowing

Allergan205 participantsStarted May 2020

Los Angeles, California, United States • Newport Beach, California, United States • Boca Raton, Florida, United States +12 more locations

Phase I/II Study of KRN330 Plus Irinotecan in Patients With Metastatic Colorectal Cancer

A Study Evaluating JUVÉDERM® VOLUMA® XC Injectable Gel for Correction of Temple Hollowing in Adult Participants ≥ 22 Years Old

Find Trials by Condition in Tennessee

Recent-Onset Type 1 Diabetes Trial Evaluating Efficacy and Safety of Teplizumab

The Afolabi Stroke Registry for Children and Young Adults With SCD in Northern Nigeria

Efficacy and Safety of Circadin® in the Treatment of Sleep Disturbances in Children With Neurodevelopment Disabilities

Long Term Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease

Treatment of Impulsive Aggression (IA) in Adolescent With ADHD in Conjunction With Standard ADHD Treatment

Automated Insulin Delivery for INpatients With DysGlycemia (AIDING) Feasibility

Investigation to Optimize Hemodynamic Management of Left Ventricular Assist Devices Using the CardioMEMS™

Study of Mogamulizumab + MEDI4736 (Durvalumab) and Mogamulizumab + Tremelimumab in Subjects w/ Advanced Solid Tumors

Study of an Anti-OX40 Monoclonal Antibody (KHK4083) in Subjects With Moderate to Severe Atopic Dermatitis

Mogamulizumab Q4week Dosing in Participants With R/R CTCL

A Study of Intraperitoneally Administered AVB-001 in Patients With Serous Adenocarcinoma of the Ovary

Safety, Tolerability, and Efficacy Study in Subjects With Advanced or Metastatic Breast Cancer

Efficacy and Safety of S95011 in Primary Sjögren's Syndrome Patients

A Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of Risdiplam (RO7034067) in Type 2 and 3 Spinal Muscular Atrophy (SMA) Participants

KHK2455 Alone and in Combination With Mogamulizumab in Subjects With Locally Advanced or Metastatic Solid Tumors

Safety Study to Evaluate Monoclonal Antibody KW-0761 in Subjects With Peripheral T-cell Lymphoma

Management of Chronic Low Back Pain in Older Adults Using Auricular Point Acupressure

A Study Of PF-04449913 In Select Hematologic Malignancies